ABSTRACT
INTRODUCTION
Gastrointestinal (GI) bleeding is one of the most common problems seen by gastroenterologists. The source of bleeding can be identified in most cases by conventional endoscopy, but approximately 5% of all remain undiagnosed (1, 2) . This type of bleeding is named obscure GI bleeding (OGIB) and is defined as bleeding of unknown origin that persists or recurs after a negative initial upper-GI and lower-GI endoscopy. It can be classified in obscure overt and obscure occult bleeding taking into account the presence or absence of clinically evident bleeding. Because OGIB is frequently due to a lesion in the small bowel it is also known as mid-gut bleeding (3) .
In the past, endoscopic conventional methods for small intestine study were sonde-type enteroscopy and push-type enteroscopy. However, if sonde-type enteroscopy has been rarely used in clinical practice (4, 5) , push-type enteroscopy only allows the examination of the proximal small bowel with a reported diagnostic yield for OGIB between 45-78% (6) (7) (8) . As a result, in 20 th century, intraoperative enteroscopy (IOE) was the gold standard for detection of lesions in the small bowel, allowing the exploration of the entire mucosa. It was in 1976 that fiber-optic endoscopes where first time used intraoperatively (9) . Since then, IOE became available as a feasible alternative, with a high diagnostic yield in patients with OGIB (10) . The standard procedure technique consists of a laparotomy followed by the insertion of a standard colonoscope (if possible pediatric), an enteroscope or even a standard gastroscope, through a small enterotomy. A per-orally and/or per-rectum technique can also been utilized.
With the introduction of wireless capsule endoscopy (CE) (M2A; Given Imaging Ltd, Yoqneam, Israel) in 2000, a new era in GI imaging began (11, 12) . Recognized its superiority over the other endoscopic methods, it became the first-line, noninvasive, diagnostic technique for the small bowel (13) (14) (15) (16) (17) (18) . Despite this incontestable progress, it was expected the development a new endoscopic device that would complement the inability to collect biopsies or perform therapy with CE. In 2001, Yamamoto et al. published their experience with double balloon enteroscopy (DBE) (19, 20) . The superiority and utility of DBE for the diagnosis and therapy of small-bowel disorders has been demonstrated in several studies, with diagnostic yields varying between 25 and 92% (10) . Compared to push-enteroscopy the diagnostic yield in OGIB was 73 versus 44% (21) . A single balloon enteroscope and a spiral overtube enteroscope have been recently developed. Single-balloon enteroscopy performance and diagnostic yield was comparable to DBE, whereas spiral enteroscopy showed a reduction in the examination time (22) (23) (24) (25) (26) .
Balloon-assisted enteroscopy is now considered the standard technique for endoscopic visualization of the small bowel. However, although it was judged that IOE would be excluded as a diagnostic and therapeutic procedure, there are some cases where balloon-assisted enteroscopy cannot be performed, where it investigates only partially the small bowel or where it cannot achieve endoscopic treatment. In that cases IOE is useful, providing complete endoscopic assessment of entire small intestine, exact detection and localization of extramural and/or luminal lesions with definitive surgical and/or endoscopic therapy during the same session.
The aim of our study was to evaluate the actual role of IOE and to assess its diagnostic and therapeutic value in patients with OGIB, in a third referral center. Intraoperative enteroscopy was performed by a team of surgeons and gastroenterologists. After a median laparotomy, adhesiolysis was performed and the small intestine was explored. If no source of OGIB was identified the endoscope was introduced via a transoral and/or transanal route or by a mid-small bowel enterotomy. Each approach took into consideration the findings of VCE, when it was performed prior to IOE. The first enteroscopies were done using conventional colonoscope or gastroscope. The latter enteroscopies were performed using a Fujinon FN450-P5/20 enteroscope (Fujinon Inc, Japan), 200-cm working length, without overtubeballoon equipment. If the transoral route was adopted, after a new investigation of upper digestive tract the endoscope was pushed forward into the jejunum, facilitated with duodenum mobilization by the surgeon, and continued through the small intestine, as far as possible, helped by the surgeon that pleated the small intestine over endoscope. If an enterotomy was necessary, the surgeon prepared the small bowel enterotomy and then placed the endoscope through a sterile sleeve in the intestinal lumen. The endoscope was then pushed up to the duodenum and next down to the cecum. Room air as insufflation agent was used. In IOE, although the gastroenterologist operates the endoscope, the insertion and withdraw of the endoscope is performed by the surgeon, therefore it is necessary a perfect collaboration of both. The mucosa was cautiously observed during insertion of endoscope, because of trauma induced by intubation and bowel manipulation could be wrongly confounded with angiectasias upon withdrawal of the endoscope. If a lesion or bleeding source was detected, endoscopic (argon plasma coagulation) or surgical treatment was performed in the same surgical session if necessary. Informed consent was obtained from all patients and/or their parents for all procedures.
PATIENTS AND METHODS

This is
Continuous variables were expressed as mean with standard deviation and range. Categorical variables were expressed with percentage. Statistical analysis of data was performed using Statistical Package for Social Sciences (SPSS) version 16.0 for Windows (SPSS, Inc., Chicago, USA).
RESULTS
Of the 19 patients submitted to IOE for evaluation of OGIB, 17 (89%) presented with obscure overt bleeding (i.e, melena or hematoquezia) and 2 (11%) with obscure occult bleeding. On average, the mean duration of OGIB history was 3.3 ± 6.4 months (range: 0-24) and a mean of 17.5 ± 18.9 (range: 2-50) blood units were transfused preoperatively (Table I ). All patients underwent at least one upper and lower endoscopy, previous to IOE. Capsule endoscopy and DBE had been performed in 10 (53%) and 5 (26%) patients, respectively. When performed, DBE was preceded by VCE in all cases. Nine patients were referred directly to IOE without previous DBE or VCE: in 3 because these exams had not been introduced yet in our Digestive Endoscopy Unit and in 6 because it was not possible to perform emergent VCE or DBE and the clinical situation needed urgent resolution. The modalities of preoperative diagnostic evaluation of OGIB are listed in table II.
In total, 21 IOE were performed (one patient required 3 IOE). They were done by transoral approach exclusively (n = 6), by combined transoral and transanal approaches (n = 2) or transparietal with enterotomy (n = 13), however, in two of these cases an additional enterotomy was required to avoid overdistension of the mesentery.
A gastroscope or colonoscope was used in 11 procedures and a 200 cm working length enteroscope in 10. The entire exploration of small intestine was possible in 63% of patients. In fact, in the 6 patients where was used exclusively the transoral approach, only in 3 (50%) the total length of the intestine was explored. This was due to the fact that a lesion or bleeding source has already been detected in the explored segment, making unnecessary extending the procedure. In the same way, of the 11 patients where was used an enterotomy approach, only in 2 (18%) the ileum was explored: in one case to evaluate the terminal ileum and an enterocolic anastomosis and in other case to assess a bleeding subepithelial lesion previously identified in CE.
Endoscopic findings
A small bowel bleeding lesion was identified in 15 (79%) patients. However, despite no small intestine lesion was found in 4 (21%) patients, in 3 of them the IOE identified an outside small intestine source of bleeding. So, the diagnostic yield of IOE, for OGIB lesions, was 94% (18/19 patients).
The leading intra-operative endoscopic findings included angiodysplasia in 6 (32%) and ulcers in 4 (21%) patients. The etiology of ulcerative lesions was attributed to non-steroidal anti-inflammatory drugs (n = 2), cytomegalovirus enteritis (n = 1) and chronic small bowel ischemia (n = 1). The other findings were small bowel Dieulafoy's lesion (n = 2), bleeding from anastomotic vessels after ileocolic resection (n = 1), multiple cavernous hemangiomas (n = 1) (Figs. 1-5 ) and bleeding ectopic jejunal varices (n = 1). In 4 (21%) patients no small bowel lesion was identified, however a colonic diverticular bleeding, a duodenal angiodysplasia and a duodenal ulcer were detected under IOE and assumed as the source of the bleeding (Table III) .
Comparison with CE and DBE
Ten patients were submitted to CE. The capsule reached the cecum at the end of the procedure in all procedures and allowed the entire visualization of the small bowel. Agreement with IOE was 70%, with discordant findings in 3 cases: in case no. 1 CE visualized one subepithelial small bowel lesion that was not recognized in IOE; in case no. 2 CE visualized one jejunal angiodysplasia but IOE only identified a duodenal angiodysplasia; in case no. 3 CE visualized a subepithelial bleeding lesion that IOE confirmed to be a bleeding angiodysplasia.
Five patients underwent DBE. The reasons to perform IOE in these patients were: incomplete investigation of the small bowel (3), unsuccessful endoscopic treatment with major bleeding (1), and precise localization and definitive surgical treatment of a small bowel lesion (1). In patients in whom IOE and DBE explored the same intestinal seg- ments there were no discordant findings. Also of note, after the introduction of DBE, the number of patients submitted to IOE increased from 1.3 to 2.2/year.
Therapy performed
Of the 18 patients with a positive finding on IOE, 14 (77.8%) were submitted to endoscopic (1/14, 7.1%), surgical treatment (12/14, 85.8%) or a combined approach (1/14, 7.1%). Argon-plasma coagulation was used in 2 patients. Segmental resection was performed in 11 patients, a reanastomosis in one and a colonic resection in another (Table III) .
Morbidity, mortality and long-term results
Six patients (31.6%) died after a mean follow-up period of 21 ± 24 months (1-72). Mortality associated to IOE was 5%: one patient developed postoperative cardiovascular complications and died after cardiac arrest within 24 hours after IOE. Of the remaining 5 patients, 3 died in relation with small bowel disease (cytomegalovirus enteritis, chronic small bowel ischemia and rebleeding from small bowel angiodysplasia).
Of the patients submitted to endoscopic and/or surgical treatment, rebleeding occurred in 21.4% (3/14): small bowel angiodysplasia treated endoscopically (1), development of new ectopic jejunal varices (1) and rebleeding from anastomotic vessels (1). Overall rebleeding rate was 26.3%. Postoperative complications included prolonged ileus (2 patients) and adverse cardiovascular events (2 patients).
DISCUSSION
In the beginning of 21 st century, CE and balloon-assisted enteroscopy revolutionized the endoscopic exploration of the small intestine, particularly in the management of OGIB. Capsule endoscopy is now the preferred method of evaluation because it is noninvasive, well-tolerated, allows the entire examination of small bowel and provides an approximate localization of the site of the bleeding, guiding further investigations and treatments. Balloon-assisted enteroscopy is considered the second-line examination for patients with OGIB and positive findings in CE requiring further exploration or therapeutic intervention (10, 27) . However, the reported rates of total small bowel intubation vary widely (ranging from 0 to 86%), hampered by the presence of intestinal adhesions of previous surgery, obesity or with operators with less experience (19, 20, 23, 25, (28) (29) (30) . Nevertheless, when balloon enteroscopy approach is directed by CE findings, one-side procedure was sufficient to achieve the lesion in almost 90% of examinations (31) .
Due to these new developments, indications of IOE have decreased during last years. It is now used as the ultimate procedure in patients where balloon-assisted enteroscopy cannot be performed or fails to investigate the entire small bowel and to achieve a definitive treatment. Curiously, in our center, the number of IOE procedures has increased after the implementation of DBE. This perhaps may be explained by a better accuracy in the diagnosis of mid-gut bleeding with the new endoscopic (CE and DBE) and imaging (CT, angiography) techniques, remaining the IOE as a last choice, namely during emergent situations when DBE was unavailable.
The main drawback of IOE is the need of laparotomy or laparoscopy, with inherent risk of adhesions formation, perforation, abdominal and wound infections and ventral hernias. Besides surgical morbidity, other complications include serosal tears, avulsion of mesenteric veins, prolonged ileus and cardiovascular events during convalescence period. It has the advantage of making possible the evaluation of all small intestine, providing a immediate surgical resolution of pathological findings. In fact, the rate of complete enteroscopy with IOE is superior to balloonassisted enteroscopy, ranging between 57 and 100% in most series (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) . In our series IOE was able to explore the complete small intestine in 63% of patients: 50% in peroral approach versus 82% in enterotomy approach. Many reports attest the failure to reach the terminal ileum in a considerable number of patients in the per-oral approach, as the limited work length of the endoscopes doesn't permit a complete inspection of small bowel (34, 36, 37) .
The ability of IOE to identify small bowel lesions has been remarkable, ranging between 70 to 100%, allowing a therapeutic procedure in 40 to 100% of these cases, with a recurrent bleeding rate between 6 to 52% (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) . This is also reflected in our results where IOE was diagnostic in 94% of the cases (18/19) , allowing a endoscopic and/or surgical therapeutic procedure in 77.8% (14/18) , with a rebleeding rate of 21.4% (3/14) . In 3 patients a duodenal or colonic source of bleeding was identified during IOE. The reasons why these lesions have been missed by upper-GI or lower-GI endoscopy are unclear. Nevertheless, in 7 to 24% of patients with OGIB that perform an small intestine study with CE or DBE, the source of blood loss is found in the stomach or the colon, within reach of conventional endoscopy (42) (43) (44) . The most common findings by IOE were vascular lesions (angiodysplasia and Dieulafoy's lesion) and ulcers. These are typical potential causes of OGIB in older patients, in accordance to the age sample of our series. The ability of IOE to identify a lesion and allow a definitive treatment was 77.8% (14/18): 1 was treated endoscopically with argon plasma coagulation, 12 were submitted to surgical treatment and 1 by a combined surgical and endoscopic approach. The other 4 patients did not require or was not indicated any intraoperative treatment. As in other series, surgery was the most frequently employed modality, taking advantage of the fact that on the other side of the small bowel worked a surgeon. Surgical treatment can grant definitive resolution and lower rates of rebleeding. Although the time of follow-up has not been extensive, taking into account just the patients submitted endoscopic and/or surgical treatment, the rebleeding rate was 21.4%, similar to other series values (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) . In fact, rebleeding is the main problem arising from the management of OGIB. Vascular diseases such as angiodysplasia are more likely to rebleed than nonvascular diseases, but surgically treated patients had lower frequency of rebleeding rate than patients submitted to medical or endoscopic treatment (28, 45) . Other potentially causes of rebleeding are incomplete surgical resection in a multifocal intestine involvement or postoperative development of new lesions in other spared segments (32) .
Ten patients underwent CE previously to IOE. In patients in whom IOE and DBE explored the same intestinal segments there were discordant findings in 3 cases, as described above. CE has been previously compared with IOE in patients with OGIB. CE had sensitivity, specificity and positive and negative predictive values of 95, 75, 95 and 86%, respectively with an agreement rate with IOE in 93% of the cases (41) . In our series, agreement between CE with IOE was good, achieving a value of 70%.
The main disadvantage of IOE over other techniques is his surgical morbidity and non-negligible associated mortality rate. Procedure-related mortality and postoperative complications have been 5 and 21%, respectively, and although most studies report a low procedure-related mortality, it has been up 17% in some series (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) . This main disadvantage, associated to the development of new deep enteroscopy modalities, had relegated this technique as a last option in the management of OGIB. In fact, after the introduction of assisted-balloon enteroscopy in our center, 90 patients with OGIB were managed with DBE and only 11 with IOE. However, in our series, five patients underwent IOE after an initial DBE, pointing out that IOE can complement balloon-assisted enteroscopy in some precise indications.
In conclusion, although IOE remains useful in the management of OGIB, achieving a diagnostic yield of 94% and allowing a definitive treatment in 77.8%, it should be reserved for patients with massive, continuous or recurrent gastrointestinal bleeding when other less invasive methods have failed to treat the source of hemorrhage or were unable to complete the investigation of the small bowel.
